144 related articles for article (PubMed ID: 15212874)
1. Bioavailability and pharmacokinetics of cyclosporine A-loaded pH-sensitive nanoparticles for oral administration.
Wang XQ; Dai JD; Chen Z; Zhang T; Xia GM; Nagai T; Zhang Q
J Control Release; 2004 Jul; 97(3):421-9. PubMed ID: 15212874
[TBL] [Abstract][Full Text] [Related]
2. [Relative bioavailability of cyclosporine A-loaded hydroxypropyl methylcellulose phthalate nanoparticles for oral administration in rats].
Wang XQ; Dai JD; Zhang Q; Zhang T; Xia GM
Yao Xue Xue Bao; 2004 Jun; 39(6):463-6. PubMed ID: 15491107
[TBL] [Abstract][Full Text] [Related]
3. Long-term studies on the stability and oral bioavailability of cyclosporine A nanoparticle colloid.
Wang XQ; Huang J; Dai JD; Zhang T; Lü WL; Zhang H; Zhang X; Wang JC; Zhang Q
Int J Pharm; 2006 Sep; 322(1-2):146-53. PubMed ID: 16787721
[TBL] [Abstract][Full Text] [Related]
4. pH-sensitive nanoparticles for improving the oral bioavailability of cyclosporine A.
Dai J; Nagai T; Wang X; Zhang T; Meng M; Zhang Q
Int J Pharm; 2004 Aug; 280(1-2):229-40. PubMed ID: 15265562
[TBL] [Abstract][Full Text] [Related]
5. [Preparation of cyclosporine A pH sensitive nanoparticles and oral pharmacokinetics in rats].
Dai JD; Wang XQ; Zhang T; Meng M; Zhang X; Lü WL; Zhang Q
Yao Xue Xue Bao; 2004 Dec; 39(12):1023-7. PubMed ID: 15813034
[TBL] [Abstract][Full Text] [Related]
6. Preparation of an alternative freeze-dried pH-sensitive cyclosporine A loaded nanoparticles formulation and its pharmacokinetic profile in rats.
Yang ZQ; Xu J; Pan P; Zhang XN
Pharmazie; 2009 Jan; 64(1):26-31. PubMed ID: 19216227
[TBL] [Abstract][Full Text] [Related]
7. [Influence of suspending agents on relative bioavailability of cyclosporine A-loaded HPMCP nanoparticles for oral administration to rats].
Wang XQ; Chen Z; Dai JD; Zhang T; Xia GM; Zhang Q
Beijing Da Xue Xue Bao Yi Xue Ban; 2004 Jun; 36(3):305-8. PubMed ID: 15205706
[TBL] [Abstract][Full Text] [Related]
8. Absorption mechanism of cyclosporine A loaded pH-sensitive nanoparticles in rats.
Wang XQ; Dai JD; Zhang H; Zhang X; Wang JC; Zhang Q
J Nanosci Nanotechnol; 2008 May; 8(5):2422-31. PubMed ID: 18572658
[TBL] [Abstract][Full Text] [Related]
9. HP55-coated capsule containing PLGA/RS nanoparticles for oral delivery of insulin.
Wu ZM; Zhou L; Guo XD; Jiang W; Ling L; Qian Y; Luo KQ; Zhang LJ
Int J Pharm; 2012 Apr; 425(1-2):1-8. PubMed ID: 22248666
[TBL] [Abstract][Full Text] [Related]
10. Sylysia 350/Eudragit S100 solid nanomatrix as a promising system for oral delivery of cyclosporine A.
Dai W; Guo Y; Zhang H; Wang X; Zhang Q
Int J Pharm; 2015 Jan; 478(2):718-25. PubMed ID: 25448562
[TBL] [Abstract][Full Text] [Related]
11. Oral bioavailability of cyclosporine: solid lipid nanoparticles (SLN) versus drug nanocrystals.
Müller RH; Runge S; Ravelli V; Mehnert W; Thünemann AF; Souto EB
Int J Pharm; 2006 Jul; 317(1):82-9. PubMed ID: 16580159
[TBL] [Abstract][Full Text] [Related]
12. PLGA nanoparticles for oral delivery of cyclosporine: nephrotoxicity and pharmacokinetic studies in comparison to Sandimmune Neoral.
Italia JL; Bhatt DK; Bhardwaj V; Tikoo K; Kumar MN
J Control Release; 2007 Jun; 119(2):197-206. PubMed ID: 17399839
[TBL] [Abstract][Full Text] [Related]
13. Melatonin-loaded silica coated with hydroxypropyl methylcellulose phthalate for enhanced oral bioavailability: Preparation, and in vitro-in vivo evaluation.
Li Y; Zhao X; Zu Y; Wang L; Wu W; Deng Y; Zu C; Liu Y
Eur J Pharm Biopharm; 2017 Mar; 112():58-66. PubMed ID: 27865856
[TBL] [Abstract][Full Text] [Related]
14. A novel use of an in vitro method to predict the in vivo stability of block copolymer based nano-containers.
Aliabadi HM; Brocks DR; Mahdipoor P; Lavasanifar A
J Control Release; 2007 Sep; 122(1):63-70. PubMed ID: 17644207
[TBL] [Abstract][Full Text] [Related]
15. Effect of atropine on gastrointestinal motility and the bioavailability of cyclosporine A in rats.
Quijano RF; Ohnishi N; Umeda K; Komada F; Iwakawa S; Okumura K
Drug Metab Dispos; 1993; 21(1):141-3. PubMed ID: 8095208
[TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetics and enhanced oral bioavailability in beagle dogs of cyclosporine A encapsulated in glyceryl monooleate/poloxamer 407 cubic nanoparticles.
Lai J; Lu Y; Yin Z; Hu F; Wu W
Int J Nanomedicine; 2010 Feb; 5():13-23. PubMed ID: 20161984
[TBL] [Abstract][Full Text] [Related]
17. [Study on preparation conditions for polylactide nanoparticles loaded cyclosporine A and its oral bioavailability in rats].
Wang XQ; Zhang T; He Y; Zhang L; Zhang Q
Yao Xue Xue Bao; 2004 Jan; 39(1):68-71. PubMed ID: 15127586
[TBL] [Abstract][Full Text] [Related]
18. Ethyl docosahexaenoate decreased Neoral absorption due to particle size enlargement.
Hirunpanich V; Sugiyama E; Sato H
Int J Pharm; 2008 Sep; 361(1-2):251-2. PubMed ID: 18577438
[TBL] [Abstract][Full Text] [Related]
19. Comparative bioavailability of the microemulsion formulation of cyclosporine (Neoral) with a generic dispersion formulation (Cicloral) in young healthy male volunteers.
Kees F; Bucher M; Schweda F; Gschaidmeier H; Burhenne J; Mikus G; Faerber L
Ther Drug Monit; 2006 Jun; 28(3):312-20. PubMed ID: 16778713
[TBL] [Abstract][Full Text] [Related]
20. Oral evaluation in rabbits of cyclosporin-loaded Eudragit RS or RL nanoparticles.
Ubrich N; Schmidt C; Bodmeier R; Hoffman M; Maincent P
Int J Pharm; 2005 Jan; 288(1):169-75. PubMed ID: 15607269
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
